← Back
Index: #97

Clinical Trials Are Poorly Optimized for Evidence Gathering

Current clinical trial designs are not sufficiently optimized for gathering robust evidence, leading to inefficiencies and suboptimal outcomes.

Foundational Capabilities (4)

Implement federated data and differential privacy systems to aggregate clinical trial data from multiple sites while ensuring patient privacy.
Promote studies conducted outside traditional clinical settings to gather real-world evidence more effectively.
Apply quasi-experimental designs to strengthen causal inference in clinical studies, improving evidence quality, and do this for wider and more unified datasets (e.g., existing medical records) and across many conditions, e.g., combined with federated data approaches. Historically it has taken 5-10 years for advanced methods to percolate into relevant areas of omics / biotechnology x clinical area. It is also changing a culture of thinking — that there exists a different kind of validation that is neither 'do a perfect experiment' nor 'I tested on an external hold-out' but a third thing.